Loading...

Integra LifeSciences Holdings Corporation

IARTNASDAQ
Healthcare
Medical - Devices
$12.37
$-0.49(-3.81%)

Integra LifeSciences Holdings Corporation (IART) Stock Competitors & Peer Comparison

See (IART) competitors and their performances in Stock Market.

Peer Comparison Table: Medical - Devices Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
IART$12.37-3.81%961.3M-32.55-$0.38N/A
ABT$128.55+0.42%223.7B16.13$7.97+1.81%
BSX-PA$122.18+2.37%175.4B230.53$0.53N/A
BSX$106.76+0.27%157.9B63.54$1.68N/A
SYK$400.41-0.04%153.1B54.06$7.41+0.83%
MDT$91.64-0.87%117.5B25.40$3.61+3.07%
EW$81.16+0.86%47.6B33.97$2.39N/A
DXCM$89.06-0.32%34.9B66.96$1.33N/A
PHG$26.81-4.32%24.8B141.05$0.19+3.30%
STE$229.27+0.39%22.6B37.24$6.16+1.00%
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

IART vs ABT Comparison July 2025

IART plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IART stands at 961.3M. In comparison, ABT has a market cap of 223.7B. Regarding current trading prices, IART is priced at $12.37, while ABT trades at $128.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IART currently has a P/E ratio of -32.55, whereas ABT's P/E ratio is 16.13. In terms of profitability, IART's ROE is -0.03%, compared to ABT's ROE of +0.32%. Regarding short-term risk, IART is more volatile compared to ABT. This indicates potentially higher risk in terms of short-term price fluctuations for IART.Check ABT's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions

;